Health Technology Assessment (HTA): A Primer for Procurement Professionals
|
|
- Meghan Meagan Chapman
- 6 years ago
- Views:
Transcription
1 Health Technology Assessment (HTA): A Primer for Procurement Professionals Dr. Tammy Clifford, Chief Scien+st & Vice President, Canadian Agency for Drugs and Technologies in Health (CADTH) Dr. Fiona A Miller, Associate Professor, Ins+tute of Health Policy, Management and Evalua+on (IHPME), University of Toronto.
2 HTA & Procurement AN INTRODUCTION TO HTA 2
3 What is HTA? (Health) technology assessment is a mul+disciplinary field of policy analysis. It studies the medical, social, ethical, and economic implica+ons of development, diffusion, and use of health technology. From INAHTA (Interna+onal Network of Agencies for Health Technology Assessment);
4 What is HTA (2)? systema+c evalua+on of proper+es, effects, and/or impacts of health care technology. It addresses the direct, indirect, intended and unintended consequences Its main purpose is to inform technology-related decision-making in health care. HTA is conducted by interdisciplinary groups drawing from a variety of methods. HTAi (
5 The Role of HTA Provide basis for informed decisions about: Adop+on/acquisi+on, diffusion, appropriate use, disinvestment/obsolescence HTA is not, in and of itself, the decision Reliable and +mely provision of (synthesized, appraised) evidence: Is it safe? For whom does it work and when? Is it be[er than what we already have/do? Does it provide value for money? Can we afford it? Can we afford not to? What else needs to be considered?
6 HTA supports evidence-informed decisions Across the lifecycle of a technology Innovation and R&D Adoption Ongoing assessment Appropriate Use Obsolescence
7 For Whom? Government policy and decision makers Public drug plan managers Regional health authori+es Hospitals and other health care facili+es Health professionals Pa+ents
8 Mul+ple Factors in Decision Making While HTA incorporates evidence on many facets of a decision (e.g., clinical, economic, ethical, legal, social) Evidence is but one input into a decision And even what is defined as evidence can differ Desire is to reduce uncertainty Not realis+c to eliminate it
9 The HTA Landscape: Canada
10 The HTA Landscape: Interna+onal
11 To be useful to decision makers, HTA must be tailored to the decision nodes of the health-care system and the needs and interests of decision makers at each of these nodes. The OECD Health Project. Health Technology and Decision Making. Paris, France: OECD
12 HTA one size does not fit all Agency/organiza+on Mandate/remit Governance Linkages to other groups/programs Report Processes Who s involved, at what point(s) and to what extent Decision making framework(s)
13 What s the HTA Process? 1. Priority Setting/Topic Selection 2. Research Question Formulation 3. Identifying the Relevant Primary Research 4. Collect and Appraise the Clinical Evidence 5. Economic Analyses: comparative cost effectiveness, impact on current budget and health systems (VALUE) 6. Evaluation of ELSIs 7. Summarize/disseminate 3 natural pockets of knowledge Systematic Review & Meta-analysis Economic Evaluation Additional aspects
14 HTA & Procurement TWO SOLITUDES? 14
15 Same, same HTA & Healthcare Procurement share Roles in adop+on and appropriate u+liza+on The front doors of healthcare systems Public policy a[en+on Fiscal pressure; value for money Principle missions High quality health systems, pa+ent outcomes
16 but different HTA Scope For clinical technologies At point of adop+on Mostly drugs (outpa+ent) Procurement Scope For clinical & non-clinical products & services Most adop+on, All diffusion
17 quite different HTA Soc regulatory regime Limited regulatory direc+ves Community of prac+ce Provides guidance to policy Procurement Strict regulatory regime Trade agreements/ statute Finance/ Treasury Board policy Ensures compliance in prac,ce
18 really, quite different HTA Touchstones Evidence-based medicine Value for money Pa+ent & social values Procurement Touchstones Compe++on, Fairness & Transparency Fraud & Corrup+on Waste
19 really, quite different HTA Adjudicate compara+ve clinical & cost effec+veness Evidence-based medicine Cri+cal appraisal of relevant clinical evidence Value for money Cost per QALY Pa+ent & social values Pa+ent preferences Ci+zen values Accountability for Reasonableness Procurement Adjudicate transparent, fair & compe++ve process Request for proposals Pre-specified criteria Mandatory requirements Envelope 1: Technical/ Quality requirements (Clinical, Service Level, Device and Product Performance Requirements) Envelope 2: Business/Financial requirements
20 Working together? (1) For adop+on HTA to evaluate high cost technologies prior to broad use Procurement to follow. Informa+on to flow Business case to be built Recommenda+ons to be usable Relevant issues evaluated Different value proposi+ons of different products iden+fied Comprehensive, not selec+ve, product review
21 Working together? (2) For op+mal use Procurement to specify need for assessments Planned spend HTA to follow Iden+fy whether products are clinically equivalent within product class Inform business case for technology variants Ex.: Rela+ve value of different colours of intraocular lens implants? Inform decisions about technology use for different pa+ent subgroups Ex.: Pay more for joint replacement technologies for younger pa+ents?
22 Working together? (3) For shared exper+se and capacity HTA as source of exper+se for procurement For apprecia+ng value, challenging business as usual Procurement as source of exper+se for HTA To understand u+liza+on, for real world outcomes
23 Two solitudes? HTA & Procurement Share goals, but Operate in very different ways Many ways to work together & value for each Requires strong connec+ons Requires transla+on across significant differences 23
24 HTA & Procurement OPPORTUNITIES TO CONNECT 24
25
26 What does CADTH consider to be a health technology? Pharmaceu+cals (includes blood and vaccines); Diagnos+cs; and Medical, dental, surgical devices and procedures.
27
28 28
29 Opportuni+es to Connect Make a request! Rapid Response Service Evidence reviews tailored to your specific informa+on needs and +meline All reports posted to cadth.ca Suggest a topic For larger assessments (HTA) For technologies that are new/emerging (horizon scan) To find out who s doing what (environmental scan) Connect with your Liaison Officer h[ps://cadth.ca/submit-a-request Check out our website/subscribe 29
30 Thanks!
December Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationIssues in Emerging Health Technologies Bulletin Process
Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More informationHealth Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities
Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and
More informationReduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?
3.3 Assessment: National health technology assessment unit 3.3.1 Introduction Health systems throughout the world are struggling with the challenge of how to manage health care delivery in resource-constrained
More informationWHO Workshop, Bangkok, Health Technology Assessment
WHO Workshop, Bangkok, 11.09.2010 Health Technology Assessment 1. Introduction to Health Technology Assessment (HTA) Berit Mørland, Norway 2. HTA & Government Keng Ho PWEE, Singapore 3. HTA and Clinical
More informationAdaptation of HTA reports: an effective way to use limited resources?
Adaptation of HTA reports: an effective way to use limited resources? Iñaki Gutiérrez-Ibarluzea, Osteba, Basque Office for HTA. Ministry for Health, Basque Government Introducing the Basque Country Basque
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationA Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data
External Review of Pan-Canadian Health Organizations Thank you for the opportunity to provide input for your ongoing review of the Pan- Canadian Health Organizations (PCHOs). This submission is made on
More informationPatient safety and optimal performance:
Patient safety and optimal performance: a holistic framework for medical devices Michael Cheng Independent Patient Safety Advocate cheng12@sympatico.ca Canadian Agency for Drugs and Technologies in Health
More informationHealth Technology Assessment (HTA) Dr Hamid Ravaghi
Health Technology Assessment (HTA) Dr Hamid Ravaghi Why? What? How? 3 Why? New technologies Cost of new technologies Limited resources Ethical questions WHAT? Health Technology Instruments, equipment,
More informationMedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)
MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017) Table of Contents Executive Summary...3 The need for healthcare reform...4 The medical technology industry
More informationCADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes
CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes Service Line: Health Technology Management Program Version: 1.0 Publication Date: September 2017 Report Length:
More informationNew methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients?
New methods, how could Norway speed up Health Technology Assessment (HTA) to the benefit of health industry, policy-makers, clinicians and patients? Department director Øyvind Melien Reviews and HTA, Norwegian
More informationChanging landscape - changing paradigms
IP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE? Department director Øyvind Melien Assessment interventions, Norwegian Institute
More informationStrategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use
Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta
More informationIP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE?
IP7: CHANGING PARADIGM IN THE EVALUATION OF THE VALUE OF MEDICAL DEVICES: WHAT MUST STAKEHOLDERS EXPECT IN THE NEW DECADE? Department director Øyvind Melien Assessment interventions, Norwegian Institute
More informationCentre for the Advancement of Health Innovations (CAHI)
Centre for the Advancement of Health Innovations (CAHI) Excellence in Clinical Innovation and Technology Evaluation Monday, April 16 th, 2012 The Old Mill Inn and Spa, Toronto ON Leslie Levin MB, MD, FRCP
More informationSURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM. New ideas & Improvements
SURGERY STRATEGIC CLINICAL NETWORK EVIDENCE DECISION SUPPORT PROGRAM 2014 Revision (v3) New ideas & Improvements Department of Surgery Evidence Decision Support Program Resource Tool Box Regional Clinical
More informationAndalusian Agency for Health Technology Assessment (AETSA)
Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction
More information13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer
13 December 2007 A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer Project Team Leela Barham Michelle Ng NERA Economic Consulting 15 Stratford Place London W1C 1BE United Kingdom Tel:
More informationEU Cooperation on Health Technology Assessment
Strategy for EU Cooperation on Health Technology Assessment Strategy for EU cooperation on Health Technology Assessment (HTA) The HTA Network is a voluntary network, set up by Directive2011/24 (article
More informationAlberta Health Services and Advancing Uptake of HTA & Innovation
Alberta Health Services and Advancing Uptake of HTA & Innovation Don Juzwishin, Candis Bilyk, Rosmin Esmail, Paule Poulin, Dr. Trevor Schuler April 5, 2011 Vancouver, British Columbia Objectives Introduction
More informationTransforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value
CADTH 2018 2021 STRATEGIC PLAN Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value Health care costs an estimated $242 billion annually
More informationHealth Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI
Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI SAMED, Annual Conference, May 29 th 2014 From «Does
More informationBuilding quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA?
Workshop on Building quality into HTA and Coverage Decision- Making Processes: What are the features of good practice in HTA? 2 nd & 3 rd December 2013 Sheraton Heathrow Airport Hotel, UK PROGRAMME Organisers:
More informationGetting the evidence: Using research in policy making
Getting the evidence: Using research in policy making REPORT BY THE COMPTROLLER AND AUDITOR GENERAL HC 586-I Session 2002-2003: 16 April 2003 LONDON: The Stationery Office 14.00 Two volumes not to be sold
More informationCanada s Research-Based Pharmaceutical Companies (Rx&D) 2015 Pre-Budget Submission House of Commons Standing Committee on Finance.
Canada s Research-Based Pharmaceutical Companies (Rx&D) 2015 Pre-Budget Submission House of Commons Standing Committee on Finance August 6, 2014 Ottawa, Ontario Introduction Rx&D represents more than 50
More informationEthical issues raised by big data and real world evidence projects. Dr Andrew Turner
Ethical issues raised by big data and real world evidence projects Dr Andrew Turner andrew.turner@oii.ox.ac.uk December 8, 2017 What is real world evidence and big data? Real world evidence is evidence
More informationWHO Regulatory Systems Strengthening Program
WHO Regulatory Systems Strengthening Program MVP RHT RSS CRS www.who.int Minimal capacity met Eligibility for vaccine PQ WHO listed NRAs WHO NRA 5 step capacity building Development of NRA benchmarking
More informationHTA, the roadmap from investment to disinvestment
HTA, the roadmap from investment to disinvestment Dr. Iñaki Gutiérrez-Ibarluzea Secretary of HTAi Osteba. Osasun Teknologien Ebaluazioaren Zerbitzua. Basque Office for HTA. Osasun Saila Ministry for Health
More informationDecision Determinants Guidance Document
Decision Determinants Guidance Document The Ontario Health Technology Advisory Committee (OHTAC) Decision-Making Process for the Development of Evidence-Based Recommendations Revised September 2010 Medical
More informationA stronger system to protect the health and safety of Canadians. Exploring the Future of the Food Regulatory Framework Under the Food and Drugs Act
A stronger system to protect the health and safety of Canadians Exploring the Future of the Food Regulatory Framework Under the Food and Drugs Act Purpose and Scope To stimulate a discussion about how
More informationPatented Medicine Prices Review Board P M P R B GUIDELINES REFORM. 15 th Annual Market Access Summit. Douglas Clark Executive Director PMPRB
Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM Douglas Clark Executive Director PMPRB 15 th Annual Market Access Summit Background Canada enacted a two-fold reform of its drug patent
More informationABHI Response to the Kennedy short study on Valuing Innovation
ABHI Response to the Kennedy short study on Valuing Innovation Introduction 1. The Association of British Healthcare Industries (ABHI) is the industry association for the UK medical technology sector.
More informationStanding Committee on the Law of Patents
E SCP/24/4 ORIGINAL: ENGLISH DATE: JUNE 29, 2016 Standing Committee on the Law of Patents Twenty-Fourth Session Geneva, June 27 to 30, 2016 PROPOSAL BY THE AFRICAN GROUP FOR A WIPO WORK PROGRAM ON PATENTS
More informationIntroducing Foresight Alliance
Introducing Foresight Alliance See What s Possible February 2016 Foresight Alliance is a rigorous, crea5ve, futures-focused consul5ng firm. We help our clients consider various ways the future might unfold
More informationSummary HTA. Methods for assessment of innovative medical technologies during early stages of development. HTA-Report Summary
Summary HTA HTA-Report Summary Methods for assessment of innovative medical technologies during early stages of development Bartelmes M, Neumann U, Lühmann D, Schönermark MP, Hagen A German Agency for
More informationAn Essential Health and Biomedical R&D Treaty
An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third
More informationPan-Canadian Trust Framework Overview
Pan-Canadian Trust Framework Overview A collaborative approach to developing a Pan- Canadian Trust Framework Authors: DIACC Trust Framework Expert Committee August 2016 Abstract: The purpose of this document
More informationGlobal Perspectives on Clinical Engineering Trends Yadin David, Ed.D., P.E., C.C.E., FAACE, FAIMBE
Second WHO Global Forum on Medical Devices Priority Medical Devices for Universal Health Coverage 22-24 November 2013, Geneva, Switzerland Global Perspectives on Clinical Engineering Trends Yadin David,
More informationEXPLORATION DEVELOPMENT OPERATION CLOSURE
i ABOUT THE INFOGRAPHIC THE MINERAL DEVELOPMENT CYCLE This is an interactive infographic that highlights key findings regarding risks and opportunities for building public confidence through the mineral
More informationProtection of Privacy Policy
Protection of Privacy Policy Policy No. CIMS 006 Version No. 1.0 City Clerk's Office An Information Management Policy Subject: Protection of Privacy Policy Keywords: Information management, privacy, breach,
More informationSHTG primary submission process
Meeting date: 24 April 2014 Agenda item: 8 Paper number: SHTG 14-16 Title: Purpose: SHTG primary submission process FOR INFORMATION Background The purpose of this paper is to update SHTG members on developments
More informationFinn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark
EUnetHTA European network for Health Technology Assessment DATABASES, REGISTRIES AND OTHER DATA CAPTURE TOOLS: HOW CAN WE AVOID MULTIPLICITY AND CREATE AN INTEGRATED DATA-CAPTURE APPROACH ALONG THE PRODUCT
More informationIPv4 Alloca+on Implica+ons
IPv4 Alloca+on Implica+ons Wholesale TPIA Service in Canada Stephan Meyer Manager, Network Technology CRTC, CANADA Who Are We? The Canadian Radio- television and Telecommunica+ons Commission (CRTC) regulates
More informationOverview of Health Technology Assessment (HTA) from Asia Pacific Perspective
Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective Hong Li, PhD., MPH Group Director, Bristol-Myers Squibb Adjunct Associate Professor University of Cincinnati, USA; and DUKE-NUS
More informationThe One Mind Strategic Plan (OMSP)
A Much Needed Approach The One Mind Strategic Plan (OMSP) If I were given an hour to save the planet, I would spend 59 minutes defining the problem and one minute resolving it Albert Einstein This is the
More informationResearching children s rights globally in the digital age
Researching children s rights globally in the digital age #LSEchildrights wifi _The Cloud Arrival, welcome and introduc2ons Jasmina Byrne, UNICEF Office of Research Mee2ng overview: context, aims, challenges
More informationTOWARD TRANSPARENCY IN HEALTH TECHNOLOGY ASSESSMENT
International Journal of Technology Assessment in Health Care, 19:1 (2003), 1 7. Copyright c 2003 Cambridge University Press. Printed in the U.S.A. TOWARD TRANSPARENCY IN HEALTH TECHNOLOGY ASSESSMENT A
More informationHealth Technology Assessment and the European Network for HTA
Health Technology Assessment and the European Network for HTA www.eunethta.eu Marcial Velasco Garrido, Technische Universität Berlin for the European Network for HTA, EUnetHTA Outline What is Health Technology
More informationI. Introduction. Cover note. A. Mandate. B. Scope of the note. Technology Executive Committee. Fifteenth meeting. Bonn, Germany, September 2017
Technology Executive Committee 31 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Draft TEC and CTCN inputs to the forty-seventh session of the Subsidiary Body for Scientific and Technological
More informationDRAFT TEXT on. Version 2 of 9 September 13:00 hrs
DRAFT TEXT on SBSTA 48.2 agenda item 5 Development and transfer of technologies: Technology framework under Article 10, paragraph 4, of the Paris Agreement Version 2 of 9 September 13:00 hrs Elements of
More informationHealth Technology Strategy 1.0. June 2004
June 2004 Prepared by the Health Technology Assessment Task Group on behalf of the Federal / Provincial / Territorial Advisory Committee on Information and Emerging Technologies WHY A PAN-CANADIAN STRATEGY?
More informationInitial draft of the technology framework. Contents. Informal document by the Chair
Subsidiary Body for Scientific and Technological Advice Forty-eighth session Bonn, 30 April to 10 May 2018 15 March 2018 Initial draft of the technology framework Informal document by the Chair Contents
More informationZayna Khayat, PhD., MaRS, Canada
Zayna Khayat, PhD., MaRS, Canada MaRSMission: improve public health & Improve health system performance, & drive the new health economy Senior Advisor, Director of EXCITE program pre-market health technology
More informationBrief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO
Brief to the Senate Standing Committee on Social Affairs, Science and Technology Dr. Eliot A. Phillipson President and CEO June 14, 2010 Table of Contents Role of the Canada Foundation for Innovation (CFI)...1
More informationInventor-Driven Product Development
Inventor-Driven Product Development Stephen Sprigle, PhD, PT; Chris Maurer, PT, ATP, Linghua Kong, PhD Rehabilitation Engineering Center on Wheeled Mobility Georgia Institute of Technology ABSTRACT Inventors
More informationEarly HTA to inform value driven market access and reimbursement planning
Early HTA to inform value driven market access and reimbursement planning Lotte MG Steuten, PhD Associate Prof. Health Technology & Services Research Program Director Health Sciences University of Twente,
More informationMedical Innovation Changing Business Models. Geneva, 5 July 2013
Medical Innovation Changing Business Models (A joint technical symposium by WHO, WIPO and WTO) Geneva, 5 July 2013 Richard Wilder Associate General Counsel Global Health Funding Options and IP Grants:
More informationUse of the Graded Approach in Regulation
Use of the Graded Approach in Regulation New Major Facilities Licensing Division Directorate of Regulatory Improvement and Major Projects Management Background Information for Meeting of the Office for
More informationProcesses and mechanisms for contextualizing scientific evidence Moving from HTA to HTPA?
Processes and mechanisms for contextualizing scientific evidence Moving from HTA to HTPA? Véronique Déry MD MSc, Sylvie Beauchamp PhD, Reiner Banken MD MSc, Lise-Ann Davignon MSc From Evidence to Policy
More informationGlobal Harmonization Task Force
Global Harmonization Task Force How to minimize risks without constraining innovation and harming free trade The role of international standards And their application at regional and national levels Cornelis
More informationAdvancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation
Advancing Health and Prosperity A Brief to the Advisory Panel on Healthcare Innovation November 2014 About ITAC ITAC is the voice of the Canadian information and communications technologies (ICT) industry
More informationrof. Dr. Michael Rodi aculty of Law and Economics niversity of Greifswald
nnovation, Technology and Employment: Energy Global Conference on Environmental Taxation, Munich, 18-20 October 2007 rof. Dr. Michael Rodi aculty of Law and Economics niversity of Greifswald 31.10.2007
More informationSAFETY ASSESSMENT METHODOLOGIES AND THEIR APPLICATION IN DEVELOPMENT OF NEAR SURFACE WASTE DISPOSAL FACILITIES ASAM PROJECT
SAFETY ASSESSMENT METHODOLOGIES AND THEIR APPLICATION IN DEVELOPMENT OF NEAR SURFACE WASTE DISPOSAL FACILITIES ASAM PROJECT B. Batandjieva, P. Metcalf (a) International Atomic Energy Agency Wagrammer Strasse
More informationUsing Foresight and Scenarios for Anticipation of Skill Needs
Using Foresight and Scenarios for Anticipation of Skill Needs Martin Bakule National Training Fund National Observatory for Employment and Training Methods in Skills Needs Anticipation: A Guide on Foresights,
More informationPharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment
Presenter: Randall Sunberg Morgan Lewis May 16, 2008 In cooper Biography Randall Sunberg partner Morgan Lewis, Princeton Phone: 609.919.6606 Randall B. Sunberg is a partner in Morgan Lewis's Business and
More informationTool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases
Tool for reducing uncertainties in the evidence generation for specialised treatments for rare diseases In 2017 the multi-stakeholder initiative was set up to: Facilitate a shared understanding of the
More informationEnvironmental Protection Agency
Good Laboratory Management: Means compliance with the correct regulations for each individual study.. Environmental Protection Agency Established 1970 To enforce environmental protection standards Clean
More informationThe City of the Future Living Lab Sauro Vicini
The City of the Future Living Lab Sauro Vicini CTO @ eservices for Life and Health San Raffaele Hospital Istanbul 2015 San Raffaele Hospital & Science Park in Milan Sauro Vicini All Rights Reserved San
More informationInteroperable systems that are trusted and secure
Government managers have critical needs for models and tools to shape, manage, and evaluate 21st century services. These needs present research opportunties for both information and social scientists,
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationOECD WORK ON ARTIFICIAL INTELLIGENCE
OECD Global Parliamentary Network October 10, 2018 OECD WORK ON ARTIFICIAL INTELLIGENCE Karine Perset, Nobu Nishigata, Directorate for Science, Technology and Innovation ai@oecd.org http://oe.cd/ai OECD
More informationHealth Technology Assessment of innovative medical devices
Health Technology Assessment of innovative medical devices Dr. Iñaki Gutiérrez-Ibarluzea Knowledge Manager Vicepresident of EuroScan International Network Osteba, Basque Office for HTA Ministry for Health
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationMeet The Expert Dr. Mike Reid
Supporting the profession by Educating DCs & Sponsoring Cutting Edge Research! Meet The Expert Dr. Mike Reid Helping You Elevate Yourself, Elevate Your Practice, & Taking You to a Higher Level ChiroSecure
More informationHealth Technology Assessment in Developing Countries: A Brief Introduction for Vietnamese Health-care Policymakers
REVIEW ARTICLE Health Technology Assessment in Developing Countries: A Brief Introduction for Vietnamese Health-care Policymakers Trung Quang Vo 1, Tran Thi Huyen Pham 1 1 Department of Pharmacy Administration,
More informationAccess to Medicines, Patent Information and Freedom to Operate
TECHNICAL SYMPOSIUM DATE: JANUARY 20, 2011 Access to Medicines, Patent Information and Freedom to Operate World Health Organization (WHO) Geneva, February 18, 2011 (preceded by a Workshop on Patent Searches
More informationSAUDI ARABIAN STANDARDS ORGANIZATION (SASO) TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY
SAUDI ARABIAN STANDARDS ORGANIZATION (SASO) TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY D8-19 7-2005 FOREWORD This Part of SASO s Technical Directives is Adopted
More informationIn-Country Shared Value Creation The Case of Ghana
In-Country Shared Value Creation The Case of Ghana 6 th Plenary Session, OECD Policy Dialogue on Natural Resource-Based Development Paris, 22 23 June 2016 Isabelle RAMDOO African Minerals Development Centre
More informationWHO / HAI Project on Medicine Prices and Availability
WHO / HAI Project on Medicine Prices and Availability Review Series on Pharmaceutical Pricing Policies and Interventions Working paper 6: The Role of Health Technology Assessment in Medicine Pricing and
More informationThe digital and trustworthy evidence ecosystem: how can health industry players join to increase value in health care and capture a global market?
The digital and trustworthy evidence ecosystem: how can health industry players join to increase value in health care and capture a global market? Per Olav Vandvik, Professor of Medicine, University of
More informationBUREAU OF LAND MANAGEMENT INFORMATION QUALITY GUIDELINES
BUREAU OF LAND MANAGEMENT INFORMATION QUALITY GUIDELINES Draft Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information Disseminated by the Bureau of Land
More informationHow can value be measured and assessed?
Dávid Dankó, PhD, MSc Corvinus University of Budapest Institute of Management david.danko at uni-corvinus.hu How can value be measured and assessed? ISPOR 5 th Asia-Pacific Conference, Taipei, 2 September
More informationTwenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years
Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationMedical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade
Medical Technology Association of NZ Proposed European Union/New Zealand Free Trade Agreement Submission to Ministry of Foreign Affairs & Trade February 2016 1 Introduction The Medical Technology Association
More informationTGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations
TGA Discussion Paper 3D Printing Technology in the Medical Device Field Australian Regulatory Considerations MTAA Response - October 2017 October 2017 Australian Regulatory Considerations Page 1 of 7 Level
More informationForesight for policy-making
Foresight for policy-making Anne-Katrin Bock Joint Research Centre Foresight and Behavioural Insights Unit Serving society Stimulating innovation Supporting legislation Outline Ø Brief introduction to
More informationVincent RIALLE. Maître de conférences-praticien hospitalier, Dr GBM, Dr éthique médicale et biologique
Vincent RIALLE Maître de conférences-praticien hospitalier, Dr GBM, Dr éthique médicale et biologique Responsable de l Unité Fonctionnelle ATMISS «Alzheimer, Technologie et Méthodes d'intervention Sanitaires
More informationCanadian Health Food Association. Pre-budget consultations in advance of the 2018 budget
Canadian Health Food Association Submission to the House of Commons Standing Committee on Finance Pre-budget consultations in advance of the 2018 budget Executive Summary Every year, $7 billion is contributed
More informationArticle 117 A Notified Body perspective, advice on how and when to engage notified bodies
TOPRA Annual Medical Devices Symposium 2017 Article 117 A Notified Body perspective, advice on how and when to engage notified bodies Theresa Jeary, Head of Notified Body Medical Devices, LRQA ENABLING
More informationImplementing Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property in the Eastern Mediterranean Region
Implementing Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property in the Eastern Mediterranean Region 1 Table of Contents LIST OF ACRONYMS AND ABBREVIATIONS -----------------------------------------------------------------------------------
More informationHTA in Norway- HTA - international challenges
NVTAG Symposium Drugs: An international perspective HTA in Norway- HTA - international challenges Berit Mørland, President HTAi Deputy director, The Norwegian Knowledge Centre for the Health Services My
More informationReflection Paper on synergies between regulatory and HTA issues. DG SANTE Unit B4 Medical products: safety, quality, innovation
Reflection Paper on synergies between regulatory and HTA issues DG SANTE Unit B4 Medical products: safety, quality, innovation STAMP meeting, 28 June 2016 Outline Aim of the Reflection Paper Drafting process
More informationManufacture of medicinal products in Italy: challenges for the Italian Medicines Agency
Manufacture of medicinal products in Italy: challenges for the Italian Medicines Agency Isabella Marta Coordinator Inspections and Certification Dept. Head Manufacturing Authorization Office Italian Medicines
More informationCOMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT. pursuant to Article 294(6) of the Treaty on the Functioning of the European Union
EUROPEAN COMMISSION Brussels, 9.3.2017 COM(2017) 129 final 2012/0266 (COD) COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT pursuant to Article 294(6) of the Treaty on the Functioning of the
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationMapping of HTA in Europe " Regulatory and Reimbursement Atlas"
CIRS- Centre for Innovation in Regulatory Science 1 CONSENSUS TRUST ACCESS Mapping of HTA in Europe " Regulatory and Reimbursement Atlas" Tina Wang Manager, HTA Programme twang@cirsci.org 20 May 2016 Brussels,
More information